Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer

Abstract

Modulation of chromatin structure via histone modification is a major epigenetic mechanism and regulator of gene expression. However, the contribution of chromatin features to tumor heterogeneity and evolution remains unknown. Here we describe a high-throughput droplet microfluidics platform to profile chromatin landscapes of thousands of cells at single-cell resolution. Using patient-derived xenograft models of acquired resistance to chemotherapy and targeted therapy in breast cancer, we found that a subset of cells within untreated drug-sensitive tumors share a common chromatin signature with resistant cells, undetectable using bulk approaches. These cells, and cells from the resistant tumors, have lost chromatin marks-H3K27me3, which is associated with stable transcriptional repression-for genes known to promote resistance to treatment. This single-cell chromatin immunoprecipitation followed by sequencing approach paves the way to study the role of chromatin heterogeneity, not just in cancer but in other diseases and healthy systems, notably during cellular differentiation and development.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41588-019-0424-9

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 54 references

Cited by

See all 466

Metadata

Authors
Grosselin, K., Durand, A., Marsolier, J., Poitou, A., Marangoni, E., Nemati, F., Dahmani, A., Lameiras, S., Reyal, F., Frenoy, O., Pousse, Y., Reichen, M., Woolfe, A., Brenan, C., Griffiths, A. D., Vallot, C., & Gérard, A.
Affiliations
  • Broad Institute (US)
  • Centre National de la Recherche Scientifique (FR)
  • HiFiBiO Therapeutics (France) (FR)
  • Université Paris Sciences et Lettres (FR)
  • Inserm (FR)
  • Institut Pasteur (FR)
  • HiFiBiO Therapeutics (United States) (US)
Corresponding author
  • Griffiths, Andrew D.
  • Vallot, Céline
  • Gérard, Annabelle
Venue
Nature Genetics
Published
2019-05-31
Volume
51
Issue
6
Pages
1060-1066
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2947608130
Cited by
466
References
54
Citations by year
2026: 25 · 2025: 47 · 2024: 65 · 2023: 57 · 2022: 86 · 2021: 80 · 2020: 81 · 2019: 23
FWCI
22.34
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
Agence Nationale de la Recherche (ANR-10-LABX-0031, ANR-10-IDEX-0001, ANR-14-CE10-0013)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
breast cancer, chromatin heterogeneity, histone modifications, H3K27me3, transcriptional repression, tumor heterogeneity, chemoresistance, targeted therapy resistance, patient-derived xenografts, droplet microfluidics, epigenetics
MeSH terms
Breast Neoplasms, Chromatin, Female, Histones, Humans, Stromal Cells, Genetic Heterogeneity, Computational Biology, Epigenesis, Genetic, Microfluidic Analytical Techniques, Chromatin Immunoprecipitation, Workflow, Single-Cell Analysis, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer. https://app.cochat.ai/papers/10.1038/s41588-019-0424-9
The paper
Grosselin, K., Durand, A., Marsolier, J., Poitou, A., Marangoni, E., Nemati, F., Dahmani, A., Lameiras, S., Reyal, F., Frenoy, O., Pousse, Y., Reichen, M., Woolfe, A., Brenan, C., Griffiths, A. D., Vallot, C., & Gérard, A. (2019). High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer. Nature Genetics. https://doi.org/10.1038/s41588-019-0424-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.